EUVIMEDEUVIMED entdecken
Crossref

Inhibition of Annexin A2 Facilitates PHB2-Mediated Mitophagy in Cardiomyocytes to Alleviate Cardiac Injury and Remodeling After Infarction

Ke-Qiong Deng iD, Zhendong Xu iD, Qiongxin Wang iD, Huan-Huan Cai iD, Di Fan iD, Qingqing Wu, Xiao-Jing Zhang iD, Peng Zhang iD, Zhi-Gang She iD, Xingguo Liu iD, Xianqing Li, Zhibing Lu iD

Circulation · 2026

DOI: 10.1161/circulationaha.125.077780 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, 2026. Verfasst von Ke-Qiong Deng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Zhongnan Hospital (K.-Q.D., Z.X., Q.W., H.-H.C., D.F., Q.W., X. Li, Z.L.), Wuhan University, China. Hauptthemen laut MEDLINE: Mitophagy, Myocytes, Cardiac, Myocardial Infarction, Ventricular Remodeling. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Mitophagy is critically involved in cardiac injury and repair after myocardial infarction (MI), whereas the annexin A family plays an important role in mitophagy. However, the intrinsic molecular underpinnings that orchestrate the homeostasis of mitophagy in the infarcted heart remain to be fully characterized. Here, we aimed to evaluate the role of ANXA2 (annexin A2) in cardiac mitophagy in response to MI. METHODS: Transcriptome analyses were conducted to identify differentially expressed genes and enriched pathways. Mitophagy, mitochondrial function, and cardiac injury and remodeling were analyzed in MI mice and neonatal rat ventricular myocytes with cardiomyocyte-specific Anxa2 knockdown or overexpression, as well as in models with Anxa2 knockdown combined with Phb2 (prohibitin 2) silencing. Immunoprecipitation, mass spectrometry, and glutathione S-transferase pull-down assays were used to identify the interacting proteins of ANXA2. RESULTS: We showed that ANXA2 was highly expressed in murine and human ischemic failing hearts, whereas increased circulating ANXA2 positively correlated with cardiac injury in patients with acute MI. Moreover, cardiomyocyte-specific Anxa2 depletion averted cardiac mitophagy inactivation, oxidative stress, cell death, and inflammatory cell infiltration, leading to significant improvements in infarct size, heart function, and cardiac remodeling after MI. Conversely, Anxa2 overexpression in cardiomyocytes suppressed mitophagy to exacerbate cardiac injury and deteriorate heart failure after MI. Moreover, Anxa2 silencing and overexpression, respectively, in neonatal rat ventricular myocytes under hypoxia in vitro recapitulated the in vivo findings on mitochondrial function and cell death. Mechanistically, we found that ANXA2 directly interacted with the mitophagy receptor PHB2 to competitively block the binding of LC3B (microtubule-associated protein 1 light chain 3 beta) with PHB2 and promote PHB2 proteasomal degradation through K48-linked polyubiquitination mediated by the E3 ligase TRIM29 (tripartite motif-containing 29), resulting in mitophagy inhibition under hypoxia. Consequently, Phb2 knockdown abrogated the protective effects of Anxa2 deficiency on mitochondrial function, oxidative stress, and cell viability in stressed myocytes in vitro, as well as on heart function and remodeling under MI in vivo. CONCLUSIONS: These findings highlight the significance of ANXA2 inhibition as a molecular brake on mitophagy inactivation in cardiomyocytes under MI and uncover an ANXA2-mediated posttranslational mechanism essential for maintaining mitochondrial homeostasis and alleviating heart failure after MI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitophagyMyocytes, CardiacMyocardial InfarctionVentricular RemodelingAnnexin A2Repressor ProteinsMitochondria, HeartAnimalsProhibitinsHumansRatsMiceMaleMice, Inbred C57BLRats, Sprague-Dawley

Stichwörter der Autor:innen

cardiomyocytemitochondrial functionmitophagymyocardial infarctionproteasomal degradation

Substanzen

ProhibitinsPhb2 protein, mouseAnnexin A2PHB2 protein, humanRepressor Proteins

Autor:innen und Institutionen

  • Department of Cardiology, Zhongnan Hospital (K.-Q.D., Z.X., Q.W., H.-H.C., D.F., Q.W., X. Li, Z.L.), Wuhan University, China.
  • Hubei Provincial Clinical Research Center for Cardiovascular Intervention (K.-Q.D., Z.X., Q.W., H.-H.C., D.F., Q.W., X. Li, Z.L.), Wuhan University, China.
  • School of Basic Medical Sciences (X.-J.Z., P.Z.), Wuhan University, China.
  • Department of Cardiology, Renmin Hospital (Z.-G.S.), Wuhan University, China.
  • Institute of Development and Regeneration (X. Liu), Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, China.
  • Institute of Myocardial Injury and Repair (K.-Q.D., Z.X., Q.W., H.-H.C., D.F., Q.W., X. Li, Z.L.), Wuhan University, China.

ORCID-Profile: Ke-Qiong Deng, Zhendong Xu, Qiongxin Wang, Huan-Huan Cai, Di Fan, Xiao-Jing Zhang, Peng Zhang, Zhi-Gang She, Xingguo Liu, Zhibing Lu

Zitieren

APA

Deng, K. Q., Xu, Z., Wang, Q., Cai, H. H., Fan, D., Wu, Q., Zhang, X. J., Zhang, P., She, Z. G., Liu, X., Li, X., & Lu, Z. (2026). Inhibition of Annexin A2 Facilitates PHB2-Mediated Mitophagy in Cardiomyocytes to Alleviate Cardiac Injury and Remodeling After Infarction. Circulation. https://doi.org/10.1161/circulationaha.125.077780

Vancouver

Deng KQ, Xu Z, Wang Q, Cai HH, Fan D, Wu Q, et al. Inhibition of Annexin A2 Facilitates PHB2-Mediated Mitophagy in Cardiomyocytes to Alleviate Cardiac Injury and Remodeling After Infarction. Circulation. 2026. doi:10.1161/circulationaha.125.077780

BibTeX
@article{Deng2026,
  author = {Deng, Ke-Qiong and Xu, Zhendong and Wang, Qiongxin and Cai, Huan-Huan and Fan, Di and Wu, Qingqing and Zhang, Xiao-Jing and Zhang, Peng and She, Zhi-Gang and Liu, Xingguo and Li, Xianqing and Lu, Zhibing},
  title = {Inhibition of Annexin A2 Facilitates PHB2-Mediated Mitophagy in Cardiomyocytes to Alleviate Cardiac Injury and Remodeling After Infarction},
  journal = {Circulation},
  year = {2026},
  doi = {10.1161/circulationaha.125.077780}
}
Kostenlos starten →